0001171843-17-006332.txt : 20171026
0001171843-17-006332.hdr.sgml : 20171026
20171026160650
ACCESSION NUMBER: 0001171843-17-006332
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171024
FILED AS OF DATE: 20171026
DATE AS OF CHANGE: 20171026
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHERWOOD CHARLES H
CENTRAL INDEX KEY: 0001244298
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 171156372
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043145961
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
4
1
formfour.xml
OWNERSHIP DOCUMENT
X0306
4
2017-10-24
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001244298
SHERWOOD CHARLES H
32 WIGGINS AVENUE
BEDFORD
MA
01730
1
1
0
0
CEO and Director
Common Stock
2017-10-24
4
S
0
3278
60.04
D
132791
D
On October 24, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 3,278 shares in multiple trades ranging from $60.00 to $60.10. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected.
/s/ Charles H. Sherwood, Ph.D.
2017-10-26